[HTML][HTML] Comprehensive analysis of the immune pattern of T cell subsets in chronic myeloid leukemia before and after TKI treatment

D Yao, J Lai, Y Lu, J Zhong, X Zha, X Huang… - Frontiers in …, 2023 - frontiersin.org
Background Immunological phenotypes and differentiation statuses commonly decide the T
cell function and anti-tumor ability. However, little is known about these alterations in CML …

Comprehensive analysis of the immune pattern of T cell subsets in chronic myeloid leukemia before and after TKI treatment

D Yao, J Lai, Y Lu, J Zhong, X Zha… - … and strategies to …, 2023 - books.google.com
Background: Immunological phenotypes and differentiation statuses commonly decide the T
cell function and anti-tumor ability. However, little is known about these alterations in CML …

[HTML][HTML] Comprehensive analysis of the immune pattern of T cell subsets in chronic myeloid leukemia before and after TKI treatment

D Yao, J Lai, Y Lu, J Zhong, X Zha, X Huang… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Background Immunological phenotypes and differentiation statuses commonly decide the T
cell function and anti-tumor ability. However, little is known about these alterations in CML …

Comprehensive analysis of the immune pattern of T cell subsets in chronic myeloid leukemia before and after TKI treatment

D Yao, J Lai, Y Lu, J Zhong, X Zha, X Huang… - Frontiers in …, 2023 - europepmc.org
Background Immunological phenotypes and differentiation statuses commonly decide the T
cell function and anti-tumor ability. However, little is known about these alterations in CML …

Comprehensive analysis of the immune pattern of T cell subsets in chronic myeloid leukemia before and after TKI treatment

D Yao, J Lai, Y Lu, J Zhong, X Zha… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Immunological phenotypes and differentiation statuses commonly decide the T
cell function and anti-tumor ability. However, little is known about these alterations in CML …

Comprehensive analysis of the immune pattern of T cell subsets in chronic myeloid leukemia before and after TKI treatment.

D Yao, J Lai, Y Lu, J Zhong, X Zha, X Huang… - Frontiers in …, 2023 - europepmc.org
Background Immunological phenotypes and differentiation statuses commonly decide the T
cell function and anti-tumor ability. However, little is known about these alterations in CML …